Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NATUS MEDICAL INCORPORATED

(NTUS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Natus Medical Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

11/04/2021 | 03:01pm EST

Natus Medical Incorporated reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 113.88 million compared to USD 102.8 million a year ago. Net income was USD 5.57 million compared to net loss of USD 9.32 million a year ago. Basic earnings per share from continuing operations was USD 0.17 compared to basic loss per share from continuing operations of USD 0.28 a year ago. Diluted earnings per share from continuing operations was USD 0.16 compared to diluted loss per share from continuing operations of USD 0.28 a year ago. For the nine months, sales was USD 344.78 million compared to USD 296.97 million a year ago. Net income was USD 11.43 million compared to net loss of USD 21.82 million a year ago. Basic earnings per share from continuing operations was USD 0.34 compared to basic loss per share from continuing operations of USD 0.65 a year ago. Diluted earnings per share from continuing operations was USD 0.34 compared to diluted loss per share from continuing operations of USD 0.65 a year ago.


ę S&P Capital IQ 2021
All news about NATUS MEDICAL INCORPORATED
01/10Natus Medical Boosts Q4, Full-Year Revenue Outlook
MT
01/10NATUS MEDICAL INCORPORATED : Announces Preliminary 2021 Fourth Quarter and Full Year Reven..
PU
01/10Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
AQ
01/10Natus Medical Incorporated Provides Preliminary Revenue Guidance for the Fourth Quarter..
CI
01/07Natus to Participate in the 24th Annual Needham Virtual Growth Conference
AQ
01/03Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February..
AQ
2021Natus Medical Names New CEO
MT
2021NATUS MEDICAL INCORPORATED : Announces Executive Transition - Form 8-K
PU
2021NATUS MEDICAL INC : Financial Statements and Exhibits (form 8-K)
AQ
2021Natus Medical Incorporated Announces Resignation of Jonathan A. Kennedy as President an..
CI
More news
Financials (USD)
Sales 2021 471 M - -
Net income 2021 23,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 31,9x
Yield 2021 -
Capitalization 753 M 753 M -
Capi. / Sales 2021 1,60x
Capi. / Sales 2022 1,55x
Nbr of Employees 1 420
Free-Float -
Chart NATUS MEDICAL INCORPORATED
Duration : Period :
Natus Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATUS MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 22,31 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Thomas J. Sullivan President, Chief Executive Officer & Director
Benjamin Drew Davies Chief Financial Officer & Executive Vice President
Joshua H. Levine Non-Executive Chairman
D. Christopher Chung Chief Medical Officer & VP-Regulatory Affairs
Ivan Pandiyan Senior Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
NATUS MEDICAL INCORPORATED-5.98%754
THERMO FISHER SCIENTIFIC-17.01%218 200
DANAHER CORPORATION-14.56%192 914
INTUITIVE SURGICAL, INC.-24.36%93 871
SIEMENS HEALTHINEERS AG-11.64%72 393
EDWARDS LIFESCIENCES CORPORATION-19.05%63 657